Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Rating of “Hold” by Brokerages

Shares of Inspire Medical Systems, Inc. (NYSE:INSP) have earned a consensus rating of “Hold” from the twenty-one analysts that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $74.8333.

Several equities analysts recently issued reports on the stock. Weiss Ratings downgraded shares of Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. decreased their price objective on shares of Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Zacks Research raised shares of Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Wells Fargo & Company reduced their target price on Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 5th. Finally, Robert W. Baird decreased their price target on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th.

Institutional Investors Weigh In On Inspire Medical Systems

Institutional investors and hedge funds have recently made changes to their positions in the company. Daiwa Securities Group Inc. increased its holdings in shares of Inspire Medical Systems by 38.7% during the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock worth $60,000 after buying an additional 130 shares during the last quarter. State of Wyoming grew its position in Inspire Medical Systems by 31.5% in the fourth quarter. State of Wyoming now owns 731 shares of the company’s stock worth $67,000 after acquiring an additional 175 shares during the period. Smartleaf Asset Management LLC increased its stake in Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after acquiring an additional 205 shares during the last quarter. Apollon Wealth Management LLC raised its position in Inspire Medical Systems by 5.6% in the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after purchasing an additional 212 shares during the period. Finally, Blair William & Co. IL raised its position in Inspire Medical Systems by 5.1% in the third quarter. Blair William & Co. IL now owns 4,865 shares of the company’s stock valued at $361,000 after purchasing an additional 234 shares during the period. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 4.0%

NYSE INSP opened at $50.38 on Friday. The company has a fifty day simple moving average of $44.89 and a 200 day simple moving average of $57.70. The company has a market cap of $1.45 billion, a P/E ratio of 11.22, a P/E/G ratio of 5.31 and a beta of 0.71. Inspire Medical Systems has a 1 year low of $38.91 and a 1 year high of $147.03.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, May 4th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.28) by $0.38. The company had revenue of $204.58 million for the quarter, compared to the consensus estimate of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Equities research analysts forecast that Inspire Medical Systems will post 0.93 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.